Edition:
United Kingdom

Paratek Pharmaceuticals Inc (PRTK.OQ)

PRTK.OQ on NASDAQ Stock Exchange Global Market

6.56USD
12 Dec 2018
Change (% chg)

-- (--)
Prev Close
$6.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
159,784
52-wk High
$19.30
52-wk Low
$6.28

Select another date:

Wed, Aug 8 2018

U.S. FDA panel backs approval of Paratek's antibiotic

A U.S. Food and Drug Administration expert panel on Wednesday voted in favor of approval of Paratek Pharmaceuticals Inc's antibiotic to treat bacterial pneumonia and skin infections.

UPDATE 1-U.S. FDA panel backs approval of Paratek's antibiotic

Aug 8 A U.S. Food and Drug Administration expert panel on Wednesday voted in favor of approval of Paratek Pharmaceuticals Inc's antibiotic to treat bacterial pneumonia and skin infections.

U.S. FDA panel backs approval of Paratek's antibiotic

Aug 8 A U.S. Food and Drug Administration expert panel on Wednesday voted in favor of approval of Paratek Pharmaceuticals Inc's antibiotic to treat bacterial pneumonia and skin infections.

Paratek antibiotic not inferior to current treatments: FDA staff

Paratek Pharmaceuticals Inc's new antibiotic for bacterial pneumonia and skin infections is not inferior to current treatments, U.S. Food and Drug Administration staff reviewers said on Monday.

UPDATE 1-Paratek antibiotic not inferior to current treatments-FDA staff

* Drug could bring in U.S. sales of $535 mln in 2025-analysts

Select another date: